ANI Pharmaceuticals to Present at Upcoming Investor Conferences

Core Viewpoint - ANI Pharmaceuticals, Inc. is actively engaging with investors through presentations at two upcoming conferences, highlighting its commitment to transparency and investor relations [1]. Company Overview - ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing innovative therapeutics [2]. - The company aims to deliver sustainable growth through its Rare Disease business, Generics business, and Brands business, targeting areas such as ophthalmology, rheumatology, nephrology, neurology, and pulmonology [2]. Upcoming Events - ANI Pharmaceuticals will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 9:00 am ET [1]. - The company will also participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 1:50 pm ET [1]. - Live and archived webcasts of these presentations will be available on the company's website for 90 days [1].